The White House and the US Food and Drug Administration have disagreed on policy for a range of issues, "from the regulation of sunscreens and asthma inhalers to the enforcement of an agency decision on a drug to prevent premature births," The New York Times reports.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.